NPI: 1932171634 · ZIONSVILLE, IN 46077 · Professional Counselor · NPI assigned 02/06/2006
Authorized official PINCINCE, DEBORAH controls 20+ related entities in our dataset. Read more
| Authorized Official | PINCINCE, DEBORAH (ADMINISTRATOR) |
| NPI Enumeration Date | 02/06/2006 |
Other providers sharing the same authorized official: PINCINCE, DEBORAH
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 13,545 | $165K |
| 2019 | 11,118 | $406K |
| 2020 | 54,030 | $502K |
| 2021 | 240,795 | $3.13M |
| 2022 | 151,044 | $1.35M |
| 2023 | 143,359 | $975K |
| 2024 | 69,208 | $348K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 100,329 | 72,539 | $1.75M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 33,096 | 25,652 | $1.46M |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 145,221 | 114,058 | $1.24M |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 15,524 | 12,121 | $701K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 19,627 | 14,087 | $483K |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 9,040 | 6,925 | $400K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 52,815 | 34,107 | $371K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 8,794 | 6,115 | $184K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 5,292 | 3,765 | $91K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 5,204 | 4,095 | $46K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 4,731 | 1,790 | $42K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 739 | 529 | $32K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 3,371 | 2,486 | $25K |
| 90674 | 1,419 | 1,134 | $16K | |
| 90686 | 1,335 | 1,063 | $12K | |
| 86580 | 2,235 | 1,583 | $10K | |
| 99201 | 593 | 414 | $8K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 97 | 72 | $3K |
| 90472 | Immunization administration, each additional vaccine (list separately) | 288 | 172 | $2K |
| 90715 | 118 | 96 | $2K | |
| 81002 | 1,231 | 846 | $1K | |
| 0071A | 193 | 137 | $902.35 | |
| 0072A | 85 | 70 | $548.85 | |
| 0031A | 144 | 94 | $455.80 | |
| 90682 | 20 | 16 | $366.47 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 97 | 68 | $336.22 |
| 0064A | 41 | 36 | $330.22 | |
| 0004A | 55 | 52 | $241.85 | |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 37 | 26 | $236.44 |
| 0011A | 62 | 57 | $165.58 | |
| 0002A | 17 | 14 | $122.79 | |
| 99401 | 31 | 24 | $106.28 | |
| 0001A | 37 | 30 | $74.42 | |
| 90746 | 15 | 12 | $59.33 | |
| 1036F | 51,414 | 40,114 | $0.00 | |
| 3008F | 39,673 | 30,996 | $0.00 | |
| 3074F | 46,308 | 36,523 | $0.00 | |
| G0008 | Administration of influenza virus vaccine | 15 | 14 | $0.00 |
| 3079F | 4,322 | 3,305 | $0.00 | |
| 90480 | 16 | 12 | $0.00 | |
| 3075F | 1,016 | 757 | $0.00 | |
| 90632 | 61 | 46 | $0.00 | |
| 3080F | 95 | 75 | $0.00 | |
| 0081A | 45 | 28 | $0.00 | |
| 0082A | 43 | 28 | $0.00 | |
| 3078F | 33,755 | 26,626 | $0.00 | |
| 1160F | 47,718 | 37,451 | $0.00 | |
| 1159F | 46,419 | 36,493 | $0.00 | |
| 3077F | 141 | 108 | $0.00 | |
| 91308 | 84 | 66 | $0.00 | |
| 0083A | 27 | 19 | $0.00 | |
| 4124F | 14 | 14 | $0.00 |